Clinical trials
Neurology clinical trials
Below are recruiting neurology clinical trials, each written for real people, not researchers. We’re tracking 380 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06657274Recruiting
Digital brain training for early memory problems
This study tests a smart digital program (app or computer-based) to help with memory, thinking, and daily life in people with early Parkinson's, mild cognitive impairment, or early memory concerns. It uses brain stimulation (TMS) along with cognitive exercises.
Brescia, ITAges 18–85 - NCT06666777Recruiting
Speech therapy and parenting for early communication skills
This study tests a program that combines speech therapy with parenting support to help young children with developmental delays improve their communication and social skills. It is designed for children aged 6 months to 5 years who have developmental challenges, and their parents.
Como, ComoAges 6 months–4.9 years - NCT06681623Recruiting
Ublituximab in older adults with relapsing MS
This study is testing how safe and effective the medication ublituximab is for older adults (ages 55–80) with relapsing multiple sclerosis. It aims to see if this treatment works well for this age group.
Foxborough, MassachusettsAges 55–80 - NCT06685744Recruiting
Tele-rehab for Parkinson's or MS
This trial tests if a home-based tele-rehabilitation program helps people with Parkinson's disease or multiple sclerosis. It aims to improve movement and daily life through guided remote sessions.
BariAges 25–85 - NCT06701630Recruiting
Italian study of daily thinking and memory scales
This study is testing new questionnaires to better understand everyday thinking and memory problems in older adults. It aims to improve how doctors identify and track conditions like mild cognitive impairment and early dementia.
Milan, MichiganAges 60 years+ - NCT06704906Recruiting
Spine fusion surgery with a new bone graft material
This study tests a new bone graft material (Fibergraft BG Putty) used with a special screw system (Viper Prime) during spine fusion surgery. It is for adults with lower back problems who need 1 to 3 vertebrae fused, and who are not smokers or have a very low bone density.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06707207Recruiting
Predicting errors during skilled tasks
This study uses brain scans (MRI and MEG) to see if we can predict when someone will make a mistake while performing a skill. It aims to understand brain activity related to errors in healthy young adults.
Bethesda, MarylandAges 18–35 - NCT06715436Recruiting
Ketogenic diet for multiple sclerosis
This study tests whether a ketogenic diet can help people with multiple sclerosis. You would follow a special high-fat, low-carb diet for a period, and the researchers will check its effects on your symptoms and overall health.
PaviaAges 18–60 - NCT06773169Recruiting
Testing an app for self-managing chronic conditions
This study tests a smartphone or computer app designed to help people with long-term health conditions like arthritis, heart disease, or stroke manage their own recovery. The goal is to see if using the app improves daily living and reduces disability.
Hamilton, OntarioAges 44–75 - NCT06778772Recruiting
Moving from child to adult epilepsy care
This study helps teens with epilepsy make a smooth switch from a children's hospital to an adult hospital. It looks at how to improve this important transition so you don't miss any care.
PaviaAges 17–18 - NCT06782074Recruiting
Epilepsy's impact on thinking and emotions in teens
This study looks at how idiopathic generalized epilepsy affects thinking skills and emotions in adolescents aged 11 to 18. It aims to better understand these effects to improve care.
PaviaAges 11–17 - NCT06797024Recruiting
Study of JY231 injection for tough nerve immune disorders
This trial tests a new injection called JY231 for people with certain hard-to-treat nerve and immune disorders that haven't improved with standard treatments. It aims to see if this experimental therapy can help control the disease when other options have failed.
Wuhan, HubeiAges 18–75 - NCT06805929Recruiting
Stroke recovery: brain signals and rehab results
This study looks at how brain signals and MRI scans change after a first stroke that affects the arm. It tests whether these signals can help predict how well rehabilitation will work.
Roma, ItalyAges 18 years+ - NCT06813612Recruiting
Play therapy for kids with specific epilepsy types
This trial tests if a play-based cognitive behavioral therapy can help children ages 6 to 10 with certain types of epilepsy. It may offer a new way to support their emotional and behavioral well-being.
PaviaAges 6–10 - NCT06819592RecruitingPhase 3
Preventing early lung infections after severe brain injury
This study tests whether giving an antibiotic (ceftriaxone) early after a severe brain injury can prevent lung infections caused by the breathing machine (ventilator). It is for adults in the ICU who recently started on a ventilator due to a brain emergency.
Kingswood, New South WalesAges 18 years+ - NCT06852703Recruiting
Studying how pregnancy inflammation affects baby brain development
This study looks for biological markers in the mother's blood that might predict how exposure to inflammation during pregnancy could change a baby's brain development. The goal is to understand these effects in healthy pregnancies and those with certain inflammatory conditions.
Pisa, PIAges 18–40 - NCT06856902Recruiting
A study on a behavioral program to improve healthcare
This study tests a behavioral program to help people stick with their healthcare plan. It aims to improve health and lower costs.
DüsseldorfAges Any age - NCT06857487RecruitingPhase 1/Phase 2
Testing an herb formula to prevent early stroke worsening
This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.
Beijing, Beijing MunicipalityAges 18–80 - NCT06864156Recruiting
Molecules and vitamin levels in long COVID with brain fog
This study looks at certain molecules (called microRNAs) and vitamin B12 levels in people who have ongoing brain-related symptoms like depression, anxiety, or fatigue after a COVID-19 infection. It may help understand why some people have long-lasting symptoms and could lead to better treatments.
Mexico City, Mexico CityAges 18–65 - NCT06876948Recruiting
Long COVID brain effects in children
This study looks at brain and nerve problems in children and teens who had COVID-19. It uses brain scans and other tests to understand long-lasting symptoms like headaches, tiredness, memory issues, or dizziness.
Pisa, PIAges 6–16 - NCT06880341Recruiting
Managing temporary brain symptoms in moyamoya surgery
This trial is testing a method to reduce temporary neurological symptoms during moyamoya disease surgery. It might help patients who are having a bypass procedure to improve blood flow to the brain.
Palo Alto, CaliforniaAges 3 years+ - NCT06882122Recruiting
Atogepant for episodic migraine: brain and body effects
This study tests a daily pill called atogepant to see how it affects the brain and body in people with episodic migraine. It may help if you have 8 to 14 migraine days a month and haven't tried CGRP treatments before.
Pavia, PAVIAAges 18–70 - NCT06883227Recruiting
Health effects of harmful algae blooms in southwest Florida
This study examines how exposure to harmful algal blooms (toxic algae in water) may affect your health. If you live in certain counties in southwest Florida, joining could help researchers learn more about these impacts.
Sarasota, FloridaAges 18 years+ - NCT06891443RecruitingPhase 3
Study of Sepofarsen for LCA type 10
This study tests an investigational RNA therapy called sepofarsen for people with Leber Congenital Amaurosis (LCA) type 10, a rare inherited eye disease that causes severe vision loss from birth. The goal is to see if it can slow or improve vision loss.
San Francisco, CaliforniaAges 6 years+
Hear when a new Neurology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurology?
- Yes. Clin2 currently lists 380 recruiting neurology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.